Clinical trials
Gallbladder clinical trials
Below are recruiting gallbladder clinical trials, each written for real people, not researchers. We’re tracking 50 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06423170RecruitingPhase 2
Camrelizumab plus chemo for unresectable gallbladder cancer
This trial tests a combination of the immunotherapy drug camrelizumab with two chemotherapy drugs (gemcitabine and oxaliplatin, known as GEMOX) for people with gallbladder cancer that cannot be surgically removed. It aims to see if this treatment can help shrink the tumor and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT05169073Recruiting
Virtual reality practice for gallbladder removal surgery
This trial tests whether virtual reality training can help surgeons perform laparoscopic gallbladder removal more effectively. It is meant for people scheduled for planned (non-emergency) gallbladder surgery due to gallstones or long-term gallbladder inflammation.
BaselAges 22–45 - NCT07488078RecruitingPhase 1
IV fluids for recovery after gallbladder surgery
This trial compares giving more or less IV fluids during gallbladder removal surgery to see which helps patients recover faster. It may help you heal better after your operation.
Lahore, Punjab ProvinceAges 18–60 - NCT06918652Recruiting
Surgery or endoscopy for high-risk gallbladder inflammation
This trial compares two minimally invasive treatments for people with severe gallbladder inflammation caused by gallstones. It aims to see which approach better helps the immune system and reduces risks for those who are too sick for standard surgery.
Pavia, PaviaAges 18 years+ - NCT07413068Recruiting
Comparing treatments for gallstones and bile duct stones
This trial looks at three different ways to treat people who have both gallstones and stones in the bile duct. It aims to find which approach works best and with the fewest complications.
Jinan, ShandongAges 18 years+ - NCT05482516RecruitingPhase 3
Testing blood test–guided treatment for GI cancers in remission
This Phase 3 study tests whether giving treatment based on a positive blood test for “minimal cancer signals” (ctDNA) can help people with certain GI cancers stay cancer-free longer. It focuses on people who have finished curative-intent therapy and currently have no visible disease on scans, but their blood test is still positive.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05702775Recruiting
Drain gallbladder with ultrasound endoscopy if surgery isn’t possible
This trial compares a new ultrasound-guided way to drain the gallbladder using an endoscope versus non-endoscopic treatments. It’s for adults with acute gallbladder inflammation (from stones) who cannot have surgery, aiming to reduce complications and improve recovery.
Pamplona, NavarreAges Any age - NCT05786716RecruitingPhase 2/Phase 3
Trastuzumab plus pertuzumab for HER2-mutated cancers
This trial tests whether combining trastuzumab and pertuzumab can treat cancers that have HER2 amplification or an activating HER2 mutation. It looks at people ages 12 and older, and may include both children/teens and adults, using the study drug based on their HER2 test results.
BelfastAges 12 years+ - NCT05893511RecruitingPhase 3
EUS drainage versus antibiotics for high-risk gallbladder inflammation
This Phase 3 study compares two approaches for people with gallstone-related acute gallbladder inflammation: a procedure called EUS drainage versus antibiotic treatment alone. It may help you avoid early surgery if you are considered high risk for immediate gallbladder removal.
Hong Kong, HONG KONGAges 18 years+ - NCT06083558Recruiting
Pain and nausea after gallbladder surgery
This study looks at pain and nausea in adults who had their first gallbladder surgery between 2016 and 2025. It uses a national registry to understand recovery and help improve care.
Sundsvall, XAges 18 years+ - NCT06123117Recruiting
Nerve block vs local painkiller for gallbladder surgery recovery
This study compares two ways of giving pain relief after gallbladder removal surgery. It tests if a nerve block (STALL) works better than injecting numbing medicine directly into the surgery site. The goal is to find which method reduces pain and the need for painkillers.
Espoo, UusimaaAges 18 years+ - NCT06192719Recruiting
Study of gallbladder cancer, dysplasia, and gallstones
This trial is studying people with gallbladder cancer, abnormal cell changes (dysplasia), or gallstones. It aims to learn more about these conditions, possibly before or after treatment, or before gallbladder removal surgery.
SaltaAges 18 years+ - NCT06246448Recruiting
Robot vs open surgery for gallbladder cancer
This trial compares robot-assisted surgery to open surgery for people with gallbladder cancer that has been found after a gallbladder removal. The goal is to see which approach is better for the radical removal of remaining cancer.
StockholmAges 18 years+ - NCT06287112Recruiting
Preventing gallbladder inflammation after bile duct drainage
This study tests whether a new drainage method can help prevent acute cholecystitis (inflammation of the gallbladder) in people who need a bile duct procedure. If you are at risk for gallbladder issues, this approach might reduce complications.
SeoulAges 19 years+ - NCT06315179Recruiting
Spatial gene study for inflammatory bowel disease
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
Seattle, WashingtonAges 6–21 - NCT06638931RecruitingPhase 2
Nivolumab for rare solid tumors with high PD-L1
This trial is testing a drug called Nivolumab (an immunotherapy) for people with rare solid tumors that have high levels of PD-L1. It might be an option if you have tried other treatments and they stopped working or caused too many side effects.
Fortaleza, CearáAges 18 years+ - NCT06699030Recruiting
Diet therapy to pass tiny gallstones
This trial tests whether a special diet can help pass tiny gallstones (smaller than 2 mm) out of your gallbladder without surgery. It might be a good option if you have very small stones and want to avoid more invasive treatments.
Lanzhou, GansuAges 18–70 - NCT06715839Recruiting
Digestive cancer imaging study with targeted antibodies
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06852287RecruitingPhase 2
Study of chemo, targeted therapy, and immunotherapy for bile duct and gallbladder cancer
This trial tests a combination of chemotherapy directly to the liver, a targeted therapy pill, and an immunotherapy drug for people with advanced bile duct or gallbladder cancer that cannot be surgically removed. The goal is to see if this triple therapy can shrink or control the cancer.
Tianjin, TiaAges 18 years+ - NCT07007832Recruiting
Bile test to diagnose unclear bile duct narrowings
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
Shanghai, ChinaAges 18–90 - NCT07282912RecruitingPhase 2
Extra treatment for certain digestive cancers with undetectable ctDNA
This trial tests if adding extra local treatments (like surgery or radiation) to usual care can improve outcomes for people with certain advanced digestive cancers that have spread to a limited number of sites. You may be eligible if your cancer has responded well to at least 4 months of therapy and your ctDNA (a sign of cancer in the blood) is undetectable.
New Haven, ConnecticutAges 18–80 - NCT02012699Recruiting
Cancer registry for people with or at risk of cancer
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
Greenwood Village, ColoradoAges 19–110 - NCT07614061RecruitingPhase 1
Cell therapy for advanced bile duct cancer
This trial tests a new treatment called BTC-Ag-T, which uses your own immune cells enhanced in the lab to fight advanced biliary tract cancer (cancer of the bile ducts or gallbladder). It's designed for patients whose cancer has spread or cannot be surgically removed and who have already received standard chemotherapy plus immunotherapy.
ShanghaiAges 18 years+ - NCT07641036RecruitingPhase 1/Phase 2
CAR-NK Cell Therapy for Advanced Biliary Tract Cancer
This trial tests a new type of immune cell therapy (CAR-NK cells) designed to target cancer cells in advanced biliary tract cancers—including bile duct and gallbladder cancers. The cells are engineered to recognize and attack cancer cells that have specific markers (HER2 and CEA), and this approach may help patients whose cancer has progressed after standard chemotherapy.
Shenzhen, GuangdongAges 18 years+
Hear when a new Gallbladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gallbladder?
- Yes. Clin2 currently lists 50 recruiting gallbladder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gallbladder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gallbladder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.